Deficient Regulators In The Immune System Responsible For Type 1 Diabetes
The main regulators of the immune system, called CD4+Treg cells, are thought to be highly involved in a large range of immune diseases. The gradual reduction in their regulating capacity seems to play a critical role in the onset of type 1 diabetes, as demonstrated in the latest study by Dr. Ciriaco Piccirillo, a researcher in the Department of Microbiology and Immunology at the Research Institute of the McGill University Health Centre and the principal investigator for this project.
Sunday, January 27, 2008
Meningitis Causes Death Of Student And Counselor In New York
Meningitis Causes Death Of Student And Counselor In New York
A guidance counselor of a school in Queens, as well as a student in Massapequa, Long Island, have both died as a result of meningitis - both in the same week. According to authorities, the guidance counselor worked at the Saint Francis Preparatory High School, Fresh Meadow. Officials are currently trying to track and meet anybody who has had contact with the counselor who died - meningitis can be passed on to another person if there is close contact.
A guidance counselor of a school in Queens, as well as a student in Massapequa, Long Island, have both died as a result of meningitis - both in the same week. According to authorities, the guidance counselor worked at the Saint Francis Preparatory High School, Fresh Meadow. Officials are currently trying to track and meet anybody who has had contact with the counselor who died - meningitis can be passed on to another person if there is close contact.
Saturday, January 26, 2008
New Research Could Help Reverse The Biological Clock For Dementia Patients
New Research Could Help Reverse The Biological Clock For Dementia Patients
Medical experts in the North-East of England believe they could have found the key to turning back the brain's biological clock and reverse the effects of dementia and memory loss. Pioneering research at the University of Sunderland has shown that regular exposure to safe low level infra-red light can improve learning performance and kick-start the cognitive function of the brain.
Beta Cell Progenitors Discovered In Adult Mouse Pancreas
Investigators of the Diabetes Research Center at the Vrije Universiteit Brussel have isolated cells from the pancreas of adult mice that formed insulin-producing beta cells. Because nobody had been able to identify these elusive progenitors from adult organisms before, their existence has been questioned. The research group of Harry Heimberg reports these findings in the January 25 issue of the leading edge scientific journal Cell.
Genaera Corporation Presents Promising Preclinical Type 2 Diabetes Data For Trodusquemine (MSI-1436) At Keystone Symposia
Genaera Corporation (Nasdaq: GENR) announced a poster presentation of preclinical data on trodusquemine (MSI-1436), Genaera's lead drug candidate for the treatment of type 2 diabetes and obesity, during the Diabetes Mellitus, Insulin Action and Resistance Keystone Symposia in Breckenridge, Colorado.
Medical experts in the North-East of England believe they could have found the key to turning back the brain's biological clock and reverse the effects of dementia and memory loss. Pioneering research at the University of Sunderland has shown that regular exposure to safe low level infra-red light can improve learning performance and kick-start the cognitive function of the brain.
Beta Cell Progenitors Discovered In Adult Mouse Pancreas
Investigators of the Diabetes Research Center at the Vrije Universiteit Brussel have isolated cells from the pancreas of adult mice that formed insulin-producing beta cells. Because nobody had been able to identify these elusive progenitors from adult organisms before, their existence has been questioned. The research group of Harry Heimberg reports these findings in the January 25 issue of the leading edge scientific journal Cell.
Genaera Corporation Presents Promising Preclinical Type 2 Diabetes Data For Trodusquemine (MSI-1436) At Keystone Symposia
Genaera Corporation (Nasdaq: GENR) announced a poster presentation of preclinical data on trodusquemine (MSI-1436), Genaera's lead drug candidate for the treatment of type 2 diabetes and obesity, during the Diabetes Mellitus, Insulin Action and Resistance Keystone Symposia in Breckenridge, Colorado.
Subscribe to:
Posts (Atom)
